Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page
- Check2 days agoChange DetectedNew metadata references have been added, including an expanded access record and a plain language summary link, while several date entries were removed from the study record. These updates adjust ancillary information and external resources without changing the study’s core details.SummaryDifference0.4%

- Check9 days agoChange DetectedThe page adds a recruitment notice 'No longer looking for participants' and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment header and updates revision notes from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check16 days agoChange DetectedRevision tag on the page changed from v3.5.4 to v3.5.5, reflecting a minor update to the page version.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded a new revision entry v3.5.4 and removed the prior entry v3.5.3 from the page's revision history.SummaryDifference0.0%

- Check45 days agoChange DetectedThe Taiwan site entry changed from Taoyuan, Taiwan, 33305 to Taoyuan City, Taiwan, 33305. This clarifies the exact city designation for that study site.SummaryDifference0.0%

- Check59 days agoChange DetectedUpdated the ClinicalTrials.gov page revision/version number from “v3.5.2” to “v3.5.3,” reflecting a site update rather than a change to the study’s details.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.